SEC Form 4 · accession 0001209191-15-064911
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bennett S Lebow
Director · 10% Owner
Period of report
Aug 6, 2015
Accepted (ET)
Aug 10, 2015 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 6, 2015 | A | 5,000 | $0.00 | A | 5,000 | D | |
| Common StockF2 | holding | — | — | — | 2,232,629 | I | By: LeBow Alpha, LLLP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $1.62 | Aug 6, 2015 | A | 18,000 | A | — | Aug 6, 2025 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1Represents shares of common stock underlying restricted stock units granted to the reporting person on August 6, 2015. The restricted stock units are fully vested on the date of the grant.
- F2These shares are owned by LeBow Alpha, LLLP ("LeBow Alpha"). The reporting person is President of the general partner of LeBow Alpha and, as such, has the power to vote and dispose of the shares owned by LeBow Alpha. The reporting person disclaims beneficial ownership of those shares owned by LeBow Alpha except to the extent of his pecuniary interest therein.
- F3The option shall vest and become exercisable in ten equal monthly installments beginning on August 31, 2015 and ending on May 31, 2016.